Cerecor (CERC) News Today → URGENT: Prepare for Biden’s Digital Dollar NOW (From Golden Crest) (Ad) Free CERC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsInsider TradesTrendsStock AnalysisCompetitorsInsider TradesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative December 19, 2023 | benzinga.comAytu BioPharma Stock (NASDAQ:AYTU) Insider TradesAugust 24, 2023 | uk.finance.yahoo.commTOR Inhibitors Global Market Report 2023May 11, 2023 | finance.yahoo.comDelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline LandscapeSeptember 28, 2022 | finance.yahoo.comEdited Transcript of AYTU.OQ earnings conference call or presentation 27-Sep-22 8:30pm GMT - Yahoo FinanceSeptember 28, 2022 | seekingalpha.comAytu BioPharma, Inc. (AYTU) CEO Josh Disbrow on Q4 2022 Results - Earnings Call Transcript - Seeking AlphaAugust 31, 2022 | marketwatch.comDiGeorge Syndrome Drug Market In-Depth Analysis Research Report 2029August 24, 2022 | streetinsider.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - StreetInsider.comAugust 24, 2022 | businesswire.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - Business WireAugust 11, 2022 | globenewswire.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireAugust 9, 2022 | streetinsider.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - StreetInsider.comAugust 8, 2022 | marketscreener.comCelldex Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K - Marketscreener.comJuly 24, 2022 | seekingalpha.comAvalo Therapeutics, Inc. (AVTX) Stock Price Today, Quote & News - Seeking AlphaJuly 15, 2022 | bizjournals.comPhiladelphia biotech news: Updates from CHOP, Helius Medical, GSK and more - Philadelphia Business Journal - The Business JournalsMay 3, 2022 | prnewswire.comThe Axial Spondyloarthritis Market is Predicted to Grow with a CAGR of 4.7% by 2032, Analyzes DelveInsight - PR NewswireMay 1, 2022 | marketwatch.comDiGeorge Syndrome Drug Market Size, Share, Industry Growth & Forecast By 2029April 8, 2022 | marketscreener.comAACR Poster Presentation: CFT7455 Phase 1/2 Cohort A - Marketscreener.comMarch 28, 2022 | benzinga.comDiGeorge Syndrome Drug Market High Demand, Size, Share, Processing Industry, And Forecast By 2029 - Benzi - BenzingaNovember 10, 2021 | businesswire.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Business WireNovember 10, 2021 | nasdaq.comModel N (MODN) Q4 Earnings & Revenues Top Estimates, Up Y/Y - NasdaqNovember 9, 2021 | finance.yahoo.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Yahoo FinanceNovember 9, 2021 | finance.yahoo.comAvalo Reports Third Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceNovember 9, 2021 | stockhouse.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - StockhouseOctober 7, 2021 | finance.yahoo.comHorizon Technology Finance Provides Third Quarter 2021 Portfolio Update - Yahoo FinanceAugust 27, 2021 | bizjournals.comInovio's experimental Covid-19 vaccine takes another step, plus other life sciences news - Philadelphia Business Journal - Philadelphia Business JournalAugust 27, 2021 | marketscreener.comCERECOR : Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc (Form 8-K) - Marketscreener.comAugust 27, 2021 | yahoo.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc. - Yahoo FinanceAugust 26, 2021 | globenewswire.comAvalo Therapeutics, Inc. Announces Corporate Name Change - GlobeNewswireAugust 26, 2021 | seekingalpha.comCerecor changes name to Avalo Therapeutics with new Nasdaq ticker - Seeking AlphaAugust 26, 2021 | finance.yahoo.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.August 2, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceAugust 2, 2021 | globenewswire.comCerecor Reports Second Quarter 2021 Financial Results and - GlobeNewswireAugust 2, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business UpdatesAugust 2, 2021 | globenewswire.comCerecor Announces Drawdown of $10 Million Tranche under its - GlobeNewswireJuly 28, 2021 | markets.businessinsider.com44 Stocks Moving In Tuesday's Mid-Day Session - Markets InsiderJuly 27, 2021 | globenewswire.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease - GlobeNewswireJuly 27, 2021 | streetinsider.comAfter-Hours Stock Movers 07/26: (CERC) (UHS) (FFIV) Higher; (BTBT) (MINM) (TDUP) Lower (more...) - StreetInsider.comJuly 27, 2021 | finance.yahoo.comCerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated PatientsJuly 26, 2021 | benzinga.comCerecor Announced Initial Phase 1b Results For CERC-002 In Moderate To Severe Crohn's Disease Patients - BenzingaJuly 26, 2021 | marketscreener.comCERECOR INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.comJuly 26, 2021 | finance.yahoo.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Yahoo Finance Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: Prepare for Biden’s Digital Dollar NOW (Ad)Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold. Click here to receive your complimentary Wealth Management Guide >> CERC Media Mentions By Week CERC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERC News Sentiment▼0.160.61▲Average Medical News Sentiment CERC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERC Articles This Week▼00▲CERC Articles Average Week Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lexicon Pharmaceuticals News Assembly Biosciences News Sol-Gel Technologies News GlycoMimetics News Alkermes News Avidity Biosciences News Axsome Therapeutics News Crinetics Pharmaceuticals News Perrigo News Prestige Consumer Healthcare News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERC) was last updated on 6/26/2024 by MarketBeat.com Staff From Our PartnersNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the big...Banyan Hill Publishing | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredLoophole for Biden’s New Digital Currency PlanHave you heard about Executive Order 14067? This lesser-known order introduced the Digital Dollar, an alarming...Golden Crest | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | Sponsored[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan ...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerecor Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerecor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.